Long-Term Stability of the Glide Control Strategy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInfinite Biomedical Technologies
About this trial
This research is intended to test whether the prescription of the Glide prosthesis control system reduces the burden of use for both patients and their clinical care team as compared to use of Pattern Recognition-based advanced myoelectric control. The goal of the study is to fill the gaps in clinically relevant knowledge to inform the prescription of prosthesis components and the rehabilitation process.
Eligibility criteria
Qualifiers
Unilateral trans-radial or trans-humeral limb loss with a healed residual limb
Candidate for 2+ degree-of-freedom (DOF) myoelectric prosthesis as determined by the study prosthetist
Age of 18 years or greater
Disqualifiers
Prior experience with Pattern Recognition or Glide control
Individuals with a residual limb that is unhealed from the amputation surgery
Individuals with easily damaged or sensitive skin who would not tolerate EMG electrodes
Significant cognitive deficits as determined upon clinical evaluation
Trial design
Treatments tested in this trial
- Glide Control System
- Pattern Recognition System
Treatment groups
12 Participants
are divided into 2 treatment groupsSponsors and collaborators
Infinite Biomedical Technologies
Lead sponsor
Medical Center Orthotics and Prosthetics
Collaborator
Source ClinicalTrials.gov